Eli Lilly EPS - Earnings per Share 2010-2024 | LLY

Eli Lilly earnings per share (EPS) for the twelve months ending December 31, 2024 was $11.71, a 101.9% increase year-over-year.

  • Eli Lilly EPS for the quarter ending December 31, 2024 was $4.88, a 101.65% increase year-over-year.
  • Eli Lilly 2024 annual EPS was $11.71, a 101.9% increase from 2023.
  • Eli Lilly 2023 annual EPS was $5.8, a 15.94% decline from 2022.
  • Eli Lilly 2022 annual EPS was $6.9, a 12.75% increase from 2021.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.

Eli Lilly EPS - Earnings per Share 2010-2024 | LLY

  • Eli Lilly EPS for the quarter ending December 31, 2024 was $4.88, a 101.65% increase year-over-year.
  • Eli Lilly 2024 annual EPS was $11.71, a 101.9% increase from 2023.
  • Eli Lilly 2023 annual EPS was $5.8, a 15.94% decline from 2022.
  • Eli Lilly 2022 annual EPS was $6.9, a 12.75% increase from 2021.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
Related Stocks
Company NameMarket
Cap
Johnson & Johnson (JNJ)$384.4B
Novo Nordisk (NVO)$375.8B
AbbVie (ABBV)$354.6B
Roche Holding AG (RHHBY)$262.5B
Merck (MRK)$221.8B
Novartis AG (NVS)$219.3B
Pfizer (PFE)$146.8B
Sanofi (SNY)$137.4B
Bayer (BAYRY)$22.6B
Innoviva (INVA)$1.1B